Detalhe da pesquisa
1.
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med
; 390(10): 875-888, 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38446675
2.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
N Engl J Med
; 389(22): 2039-2051, 2023 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37870976
3.
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
Lancet Oncol
; 25(1): 46-61, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38101431
4.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med
; 385(20): 1856-1867, 2021 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34534429
5.
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
J Oncol Pharm Pract
; : 10781552241241004, 2024 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38613329
6.
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 24(4): 392-402, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36878237
7.
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(9): 989-1001, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37591293
8.
Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study.
Cancer
; 129(1): 118-129, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36308296
9.
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.
Acta Oncol
; 62(4): 381-390, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37083566
10.
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer.
Future Oncol
; 19(37): 2445-2452, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37701986
11.
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?
Medicina (Kaunas)
; 59(3)2023 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36984558
12.
The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas.
Medicina (Kaunas)
; 59(8)2023 Aug 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37629761
13.
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Lancet
; 397(10274): 592-604, 2021 02 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33581821
14.
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.
Future Oncol
; 18(10): 1235-1244, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35081732
15.
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
Lancet
; 395(10236): 1547-1557, 2020 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32416780
16.
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2040-2051, 2018 11 22.
Artigo
Inglês
| MEDLINE | ID: mdl-30280635
17.
Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?
J Oncol Pharm Pract
; 27(6): 1388-1394, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32847482
18.
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.
J Oncol Pharm Pract
; 27(7): 1623-1630, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33050804
19.
A comparison of metacognitive factors among patients with cancer and the control group.
Psychooncology
; 27(4): 1277-1283, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29466609
20.
Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
World J Urol
; 35(7): 1103-1110, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27812752